CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-14 | Duey Marc Director | Purchase | +190 | $2.58 | $490 | 210,113 |
| 2024-10-14 | Gilad Oren President/CEO | Purchase | +1,000 | $2.59 | $3K | 332,645 |
| 2024-10-11 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | +50 | $2.46 | $123 | 19,368 |
| 2024-10-11 | Seizinger Bernd R. Director | Purchase | +10,000 | $2.68 | $27K | 44,730 |
| 2024-10-10 | Gilad Oren President/CEO | Purchase | +150 | $2.54 | $381 | 331,645 |
| 2024-10-10 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | +450 | $2.61 | $1K | 19,318 |
| 2024-06-20 | Seizinger Bernd R. Director | Grant or award | +1,045 | 34,730 | ||
| 2024-06-20 | Seizinger Bernd R. Director | Grant or award · Stock Options (Right to Buy) | +4,185 | 4,185 | ||
| 2024-06-20 | Pamukcu Rifat Director | Grant or award | +1,045 | 4,401 | ||
| 2024-06-20 | Pamukcu Rifat Director | Grant or award · Stock Options (Right to Buy) | +4,185 | 4,185 | ||
| 2024-06-20 | Peters Richard Director | Grant or award | +1,045 | 2,074 | ||
| 2024-06-20 | Peters Richard Director | Grant or award · Stock Options (Right to Buy) | +4,185 | 4,185 | ||
| 2024-06-20 | HENNEMAN JOHN B III Director | Grant or award | +1,045 | 9,184 | ||
| 2024-06-20 | HENNEMAN JOHN B III Director | Grant or award · Stock Options (Right to Buy) | +4,185 | 4,185 | ||
| 2024-06-20 | Grissinger Michael Director | Grant or award | +1,045 | 1,844 | ||
| 2024-06-20 | Grissinger Michael Director | Grant or award · Stock Options (Right to Buy) | +4,185 | 4,185 | ||
| 2024-06-20 | Duey Marc Director | Grant or award | +1,045 | 209,923 | ||
| 2024-06-20 | Duey Marc Director | Grant or award · Stock Options (Right to Buy) | +4,185 | 4,185 | ||
| 2024-05-01 | Mirza Nadeem Q. Chief Medical Officer | Grant or award | +6,730 | 6,730 | ||
| 2024-05-01 | Mirza Nadeem Q. Chief Medical Officer | Grant or award · Stock Options (Right to Purchase) | +26,920 | 26,920 |
Page 4 of 10 · 197 trades